AlphaBlog
What moved, why, and what to watch.
✓ Subscribed
-
Organon Gets a Bid, and a Brutal Verdict
Sun Pharma agreed to buy $OGN for $14 a share, putting a hard number on what public markets thought of the business. The spread says investors believe the deal is real — but not quite risk-free.
🎧 5m -
Intel’s 24% Pop: The Market Smells a Turnaround
Semis lit up and $INTC did the loudest victory lap: +23.6% on monster volume. The question isn’t whether the move is impressive—it’s whether it’s durable.
